FINANCIAL RELEASES

Paris, 26 September 2022: Global Bioenergies’ Board of Directors met today and approved the H1 2022 financial statements, which have been audited by the Statutory Auditor and present a smaller loss…

Group net loss of €11.8m in 2021 Gross cash position of €20.9m at 31 December 2021   Paris, 2 March 2022: The Board of Directors of Global Bioenergies, at its…

Evry, 31 January 2022: TP ICAP Midcap has initiated coverage of the Global Bioenergies share (Euronext Growth: ALGBE) and today publishes a detailed analysis for its clients describing the Group’s…

Evry, 14 December 2021: Global Bioenergies (the “Company”) is today announcing the successful completion of its capital increase for a total amount of €14.5M, without preferential subscription rights for shareholders…

Capital increase aimed at institutional investors and at retail investors (via the PrimaryBid platform) Irrevocable subscription commitments from the L’Oréal group and the Cristal Union group, the historical shareholders Closing…

Evry, 09 November 2021: Kepler Cheuvreux has initiated coverage of the Global Bioenergies share (Euronext Growth: ALGBE) and today publishes a 50-page report setting out the stages of the Group’s development,…

Evry, 4 October 2021: Global Bioenergies (Euronext Growth: ALGBE), announced today that it will present at the Lytham Partners Fall 2021 Investor Conference on October 6, 2021 at 9:30 AM…

Group net loss of €7.6m in H1 2021 Gross cash position of €12.1m at 30 June 2021 Pierre Monsan joins the Board of Directors   Evry, 28 September 2021: Global…

Net loss for the Group of €12.7m in 2019, an improvement of €0.9m compared to 2018 Cash position of €16.6 million at 31 December 2019 Ms. Corinne Granger joins the…